IFNA1 and cancer: Searching for the effect of anti PD-1 blockade immunotherapy on cancer genomic evolution, Zaretsky et al. found that melanoma patients treated with anti-PD1 acquired mutations in the genes related to IFN and antigen presentation pathways [97].